FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 02/09/2006 |
3. Issuer Name and Ticker or Trading Symbol
ACORDA THERAPEUTICS INC [ ACOR ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Series E-1 Convertible Preferred Stock | (1) | (1) | Common Stock | 53,640(2) | $13.806 | I | See Footnotes(3) |
Series E-1 Convertible Preferred Stock | (1) | (1) | Common Stock | 17,880(2) | $13.806 | I | See Footnotes(4) |
Series E-2 Convertible Preferred Stock | (1) | (1) | Common Stock | 163,700(2) | $13.806 | I | See Footnotes(3) |
Series E-2 Convertible Preferred Stock | (1) | (1) | Common Stock | 54,566(2) | $13.806 | I | See Footnotes(4) |
Series H Convertible Preferred Stock | (1) | (1) | Common Stock | 24,453(2) | $15.3348 | I | See Footnotes(3) |
Series H Convertible Preferred Stock | (1) | (1) | Common Stock | 8,150(2) | $15.3348 | I | See Footnotes(4) |
Series I Convertible Preferred Stock | (1) | (1) | Common Stock | 67,945(2) | $17.1132 | I | See Footnotes(3) |
Series I Convertible Preferred Stock | (1) | (1) | Common Stock | 22,647(2) | $17.1132 | I | See Footnotes(4) |
Series J Convertible Preferred Stock | (1) | (1) | Common Stock | 98,116(2) | $7.644 | I | See Footnotes(3) |
Series J Convertible Preferred Stock | (1) | (1) | Common Stock | 32,704(2) | $7.644 | I | See Footnotes(4) |
Explanation of Responses: |
1. The convertible preferred stock is convertible at any time, at the holder's discretion, and has no expiration date. |
2. The number of shares underlying convertible preferred stock in column 3 of Table II represents the number of shares of Common Stock of the Issuer that the convertible preferred stock will automatically convert into upon the closing of the Issuer's initial public offering. |
3. These shares are held by Vector Later-Stage Equity Fund II (QP), L.P. ("Vector QP"). According to information provided by Vector QP, Mr. Phillips could be deemed to have shared voting and dispositive power with respect to the shares of stock held by Vector QP. However, Mr. Phillips disclaims beneficial ownership except to the extent of his indirect pecuniary interest therein, and this report shall not be deemed to be an admission that he is the beneficial owner of these securities for purposes of Section 16. |
4. These shares are held by Vector Later-Stage Equity Fund II, L.P. ("Vector"). According to information provided by Vector, Mr. Phillips could be deemed to have shared voting and dispositive power with respect to the shares of stock held by Vector. However, Mr. Phillips disclaims beneficial ownership except to the extent of his indirect pecuniary interest therein, and this report shall not be deemed to be an admission that he is the beneficial owner of these securities for purposes of Section 16. |
Remarks: |
Exhibit List - Exhibit 24 - Power of Attorney |
/s/ Michelle Meyers, by power of attorney | 02/09/2006 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |